Guard Therapeutics
Biotechnology Research · 2 Employees
Email Address: info@guardtherapeutics.com
- Overview
- Employees
Access 9 Verified Employees Profiles for Guard TherapeuticsUnlock Free Contacts Now
About
Guard Therapeutics is developing innovative therapies focusing on kidney diseases. The company's lead clinical asset, RMC-035, is in phase 2b development for the prevention and treatment of kidney injuries in patients undergoing open heart surgery. The company also has preclinical candidate drugs intended for the treatment of chronic kidney disease, targeting specific disease segments such as FSGS, IgAN, Alport Syndrome and DKD.
Listed on Nasdaq First North Growth Market.
Website
Year Founded
2008
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Nybrogatan 34
Stockholm, SE
Keywords
--
Location
- Nybrogatan 34 Stockholm, SE
Email Formats
Sign up for free credits and discover verified email addresses of Guard Therapeutics
FormatExamples
first + last
andywarhol@guardtherapeutics.com
first_initial + last
awarhol@guardtherapeutics.com
first + last_initial
andyw@guardtherapeutics.com
first
andy@guardtherapeutics.com
last
warhol@guardtherapeutics.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Guard Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.